Curis Employee Directory

Curis corporate office is located in 128 Spring St Ste 500 Bldg C, Lexington, Massachusetts, 02421, United States and has 11-50 employees.

Likely to Engage tag.Highly Engaged Employees

Employees by Department

Departments

Number of employees

Operations

9

C-Suite

6

Medical & Health

5

Finance

5

Engineering & Technical

4

Legal

3

Marketing

1

Curis CEO

James Dentzer, President & Chief Executive Officer at Curis
United States flag for contact location.
James DentzerPresident & Chief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Curis

  • Diantha Duvall, Chief Financial Officer at Curis
    United States flag for contact location.
    Diantha Duvall

    Chief Financial Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Curis Global Presence

globalPresence illustration
North America11-50
Asia1-10
Europe1-10
Australia1-10

Index of contact profiles from Curis

Hundreds of professionals searching for Curis have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
123

Former Employees at Curis

Explore people who held key positions, contributed to Curis's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Massachusetts, United States

Frequently Asked Questions Regarding Curis Employees

How many employees does Curis have?
Curis has 11-50 employees
Who is the CEO of Curis?
Curis’s CEO is James Dentzer
Who is the CFO of Curis?
Curis’s CFO is Diantha Duvall
Who are Curis key employees?
Some of Curis key employees are Diantha Duvall
Where is Curis located?
Curis’s headquarters are located at 128 Spring St Ste 500 Bldg C, Lexington, Massachusetts, 02421, United States
How do I contact Curis?
Curis Contact Info: Phone number: (617) 503-6500 Website: www.curis.com
What does Curis do?

Curis, Inc. is a biotechnology company headquartered in Lexington, Massachusetts, focused on discovering, developing, and commercializing innovative cancer therapeutics. Its clinical-stage pipeline includes emavusertib, an oral IRAK4 kinase inhibitor being studied for relapsed or refractory hematologic malignancies, and fimepinostat, a dual HDAC an... d PI3K inhibitor for diffuse large B-cell lymphoma. Curis also collaborates with Aurigene Discovery Technologies on immuno-oncology and precision oncology programs and has previously partnered with Genentech and Roche on cancer therapeutics.Read More

Is Curis a public company?
Yes, Curis is a public company and is traded under the symbol CRIS
See more information about Curis Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.